Login / Signup

Management and outcomes of congenital nasolacrimal duct obstruction in trisomy 21 patients vs. non-trisomy 21 patients within a paediatric population: a 5-year follow-up.

Matthew Thomas FenechAnkur RajRutika DodejaDamien C M Yeo
Published in: Orbit (Amsterdam, Netherlands) (2024)
The overall success rate after primary S&P was 55.9%. Our results suggest that in trisomy 21 patients suffering from CNLDO, a one-stage intervention with primary monocanalicular intubation should be considered instead of sequential approach.
Keyphrases
  • end stage renal disease
  • ejection fraction
  • chronic kidney disease
  • randomized controlled trial
  • intensive care unit
  • patient reported outcomes
  • skeletal muscle
  • glycemic control